Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access program

Mark A. Schroeder, Parameswaran N. Hari, Amy Blithe, Dilan Paranagama, Valkal Bhatt, John F. DiPersio

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access program'. Together they form a unique fingerprint.

Medicine & Life Sciences